Holds one active US DMF for dapoxetine, filing since 2020. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for dapoxetine, filing since 2020. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for dapoxetine. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Registered with SFDA (Saudi Arabia) for dapoxetine. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Registered with SFDA (Saudi Arabia) for dapoxetine. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Registered with SFDA (Saudi Arabia) for dapoxetine. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
This page filters the worldwide Dapoxetine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for dapoxetine and what filings they hold.
Chat with Fred, your AI analyst